- Report
- November 2025
- 307 Pages
Global
From €6287EUR$6,995USD£5,514GBP
- Report
- July 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,690GBP
- Report
- September 2025
- 150 Pages
Global
From €2291EUR$2,549USD£2,009GBP
€2696EUR$2,999USD£2,364GBP
- Report
- June 2025
- 140 Pages
Global
From €2291EUR$2,549USD£2,009GBP
€2696EUR$2,999USD£2,364GBP
- Report
- April 2025
- 135 Pages
Global
From €2291EUR$2,549USD£2,009GBP
€2696EUR$2,999USD£2,364GBP
- Report
- June 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,690GBP
- Report
- April 2025
- 120 Pages
Global
From €5348EUR$5,950USD£4,690GBP
- Report
- April 2025
- 120 Pages
Global
From €5348EUR$5,950USD£4,690GBP
- Report
- February 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,690GBP
- Report
- May 2025
- 200 Pages
Global
From €2238EUR$2,490USD£1,963GBP
- Report
- January 2025
- 182 Pages
Global
From €4045EUR$4,500USD£3,547GBP
- Report
- October 2025
- 194 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- October 2025
- 195 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- October 2025
- 188 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- October 2025
- 186 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- August 2025
- 188 Pages
Global
From €3186EUR$3,545USD£2,794GBP
€3540EUR$3,939USD£3,105GBP
- Report
- November 2025
- 577 Pages
Global
From €5258EUR$5,850USD£4,611GBP
- Report
- November 2025
- 474 Pages
Global
From €5258EUR$5,850USD£4,611GBP
- Report
- November 2025
- 174 Pages
Global
From €5258EUR$5,850USD£4,611GBP
- Report
- October 2025
- 250 Pages
Global
From €4036EUR$4,490USD£3,539GBP

The Protein Biomarker market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Protein biomarkers are proteins that can be used to detect and diagnose diseases, as well as to monitor the progression of a disease or the effectiveness of a treatment. They are used in a variety of applications, such as drug discovery, diagnostics, and personalized medicine.
The Protein Biomarker market is driven by the increasing demand for personalized medicine, as well as the growing prevalence of chronic diseases. Additionally, technological advancements in proteomics have enabled the development of more accurate and cost-effective biomarkers.
Some companies in the Protein Biomarker market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, and PerkinElmer. Show Less Read more